Condensed Consolidated Statements of Earnings (unaudited) - USD ($) shares in Millions, $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Income Statement [Abstract]
Net Sales	$ 2,026.9	$ 1,226.1	$ 3,874.3	$ 3,009.9
Type of Revenue [Extensible List]	us-gaap:ProductMember	us-gaap:ProductMember	us-gaap:ProductMember	us-gaap:ProductMember
Cost of products sold, excluding intangible asset amortization	$ 581.6	$ 424.5	$ 1,098.0	$ 911.6
Type of Cost, Good or Service [Extensible List]	us-gaap:ProductMember	us-gaap:ProductMember	us-gaap:ProductMember	us-gaap:ProductMember
Intangible asset amortization	$ 154.6	$ 147.7	$ 310.1	$ 295.3
Research and development	180.5	87.7	274.9	186.1
Selling, general and administrative	817.4	665.0	1,587.5	1,493.9
Goodwill and intangible asset impairment	16.3	33.0	16.3	645.0
Restructuring and other cost reduction initiatives	19.6	28.0	41.4	73.0
Quality remediation	11.0	9.7	21.2	26.1
Acquisition, integration, divestiture and related	25.4	2.2	38.8	6.6
Operating expenses	1,806.4	1,397.8	3,388.2	3,637.6
Operating Profit (Loss)	220.5	(171.7)	486.1	(627.7)
Other income, net	8.1	3.8	15.4	6.8
Interest expense, net	(54.7)	(54.0)	(107.0)	(104.9)
Earnings (loss) before income taxes	173.9	(221.9)	394.5	(725.8)
Provision (benefit) for income taxes	31.4	(13.7)	54.3	(8.5)
Net Earnings (Loss)	142.5	(208.2)	340.2	(717.3)
Less: Net earnings (loss) attributable to noncontrolling interest	0.6	(1.6)	0.2	(2.2)
Net Earnings (Loss) of Zimmer Biomet Holdings, Inc.	$ 141.9	$ (206.6)	$ 340.0	$ (715.1)
Earnings (Loss) Per Common Share
Basic	$ 0.68	$ (1.00)	$ 1.63	$ (3.46)
Diluted	$ 0.67	$ (1.00)	$ 1.62	$ (3.46)
Weighted Average Common Shares Outstanding
Basic	208.6	206.8	208.3	206.6
Diluted	210.7	206.8	210.4	206.6